Erika Borlenghi
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols.
Journal: Bone marrow transplantation
Published: March 18, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.
Journal: British journal of haematology
Published: February 25, 2026
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib.
Journal: Haematologica
Published: January 14, 2026
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: November 30, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 18, 2025
Venetoclax plus hypomethylating agents as effective bridge therapy to allogeneic stem cell transplant in relapsed/refractory acute myeloid leukaemia: A subanalysis of the AVALON study.
Journal: British journal of haematology
Published: July 29, 2025
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.
Journal: Cancer
Published: May 06, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.
Journal: American journal of hematology
Published: March 28, 2025
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex disease.
Journal: British journal of haematology
Published: March 26, 2025
Last Updated: 09/26/2026